Treprostinil Palmitil
AssetAlso TPIP, INS-1009
Prodrug of treprostinil that activates prostacyclin receptors to dilate pulmonary vessels.
- Stage
- Phase 3
- Modality
- Small molecule
- Target
- PTGIR
- 3
- Indications
- 2
- Trials
- 1
- Developer
Indications
3Interstitial lung disease
Phase 3, Recruiting, NCT07179380, clinicaltrials.gov, 16 Oct 2026
Pulmonary arterial hypertension
Phase 3, Recruiting, NCT07481981, clinicaltrials.gov, 10 Oct 2026
Pulmonary hypertension
Phase 3, Recruiting, NCT07179380, clinicaltrials.gov, 16 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners1
- Trials2
- Competitors8
- Signals3
Every asset’s record: target, stage, trials and the evidence behind it.